Vergoeding 2020-2024 voor ATC-subgroep L01EA : Bcr-abl-tyrosinekinaseremmers

  • Raming voor de totale Zvw-populatie
  2020 2021 2022 2023* 2024*
L01EA01 Imatinib 10.318.671 8.709.710 2.558.770 2.220.970 1.313.286
L01EA02 Dasatinib 15.945.772 13.749.055 12.489.184 4.564.455 2.167.414
L01EA03 Nilotinib 11.488.565 9.927.758 8.467.679 7.773.622 6.069.474
L01EA04 Bosutinib 2.886.077 3.304.610 3.267.928 3.428.903 3.261.749
L01EA05 Ponatinib 2.962.238 3.191.722 2.507.659 2.956.456 2.630.208
L01EA06 Asciminib . . . 2.179.751 2.561.637
Totaal 43.601.324 38.882.854 29.291.221 23.124.157 18.003.769